# Orchid **Source:** https://geo.sig.ai/brands/orchid **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** orchid.health **Last Updated:** 2026-04-14 ## Summary Wilmington DE YC W23 AI clinical notes EHR for mental health therapists; $728K total ($500K YC seed Oct 2023) with HIPAA-compliant AI notes and EHR integration competing with SimplePractice for independent therapist documentation. ## Company Overview Orchid is a Wilmington, Delaware-based AI-powered EHR platform for mental health professionals — backed by Y Combinator (W23) with $728,000 in total funding including a $500,000 seed in October 2023 from Y Combinator — providing independent mental health clinicians (therapists, psychologists, counselors) with HIPAA-compliant AI clinical notes that integrate with any existing EHR, automating note-taking to free time for patient care. Launched Orchid AI in July 2024, with e-prescribing planned for 2025, Orchid streamlines the administrative workflows and clinical documentation burden that forces mental health professionals to spend 2-3 hours daily on paperwork that competes with patient care time. Founded in 2020, targeting the solo and small group independent mental health practice market. Orchid's AI clinical documentation platform addresses the administrative time burden that is accelerating therapist burnout: a licensed therapist providing 30 client sessions weekly writes a progress note after each session (documenting the client's presenting concerns, therapeutic interventions used, response to treatment, and plan for next session) — adding 3-5 hours of documentation weekly to the clinical workload. Mental health documentation is particularly complex: HIPAA privacy requirements, insurance audit requirements for medical necessity, and clinical quality standards require notes that are both legally defensible and clinically useful. Orchid's AI notes (recording session audio with consent, generating a structured progress note that the therapist reviews and approves) reduces the post-session documentation from 10-15 minutes to 2-3 minutes of review — recovering the evening hours that therapists currently spend catching up on documentation. In 2025, Orchid competes in the mental health EHR, AI clinical documentation, and therapist practice management market with SimplePractice (mental health practice management, $55M raised), TherapyNotes (mental health EHR, dominant independent practice), and Heidi Health (AI medical notes, $10M raised) for independent mental health clinician AI documentation and practice management platform adoption. Y Combinator W23 backing connects Orchid with the digital health and healthcare SaaS investment community. The capital-efficient $728K trajectory (versus the $50M+ raises of SimplePractice and TherapyNotes) reflects the lean product-led growth approach in the well-defined independent therapy practice market. The 2025 strategy focuses on growing the independent therapist and group practice market through professional association partnerships, building the billing and insurance claim submission for revenue cycle management within the platform, and expanding the AI documentation quality features (treatment plan generation, outcome measure tracking). ## Frequently Asked Questions ### What is Orchid? Orchid is a Wilmington, Delaware-based healthcare technology company that provides an AI-powered EHR platform specifically designed for mental health professionals. The company offers HIPAA-compliant AI clinical notes solutions that automate note-taking and streamline administrative workflows, allowing clinicians to focus more time on patient care. ### What products and services does Orchid offer? Orchid offers an AI-powered EHR platform for mental health professionals, featuring HIPAA-compliant AI clinical notes that integrate with any existing EHR system. The platform automates note-taking, streamlines administrative workflows and clinical processes, with e-prescribing capabilities planned for 2025. ### Who is Orchid's target customer? Orchid targets independent mental health professionals and clinicians who need to streamline their clinical documentation and administrative workflows. ### When was Orchid founded? Orchid was founded in 2020. ### Where is Orchid located? Orchid is based in Wilmington, Delaware. ### How much funding has Orchid raised? Orchid has raised $728K in total funding, including $228K in seed funding in March 2021 and $500K in seed funding from Y Combinator in October 2023. ### What are Orchid's key achievements? Orchid participated in Y Combinator's Winter 2023 batch and successfully launched Orchid AI in July 2024. The company has raised $728K in total funding to date. ### What technology approach does Orchid use? Orchid uses HIPAA-compliant AI technology to automate clinical note-taking and documentation. The platform integrates with any existing EHR system and uses AI to streamline administrative workflows and clinical processes. ### How does Orchid help mental health professionals? Orchid automates manual note-taking and administrative workflows, freeing up more time for mental health professionals to focus on patient care. The platform's AI-powered clinical notes integrate seamlessly with existing EHR systems. ### What are Orchid's recent developments? Orchid launched Orchid AI in July 2024, bringing HIPAA-compliant AI clinical notes to market. The company is planning to add e-prescribing capabilities to the platform in 2025. ## Tags healthtech, b2b, b2c, ai-powered, erp, automation, north-america --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*